Table 1. Characteristics of AML samples.
Patient n° | Age | Diagnosis | FAB | Cyto | Phenotype |
---|---|---|---|---|---|
P_1 | 67 | APL | M3 | t(15;17) | DR-, CD34-, CD13+, CD33+, CD117+, CD45RA+, CD45RO- |
P_2 | AML | ||||
P_3 | AML | 46, XX | CD13+, CD33+, CD24+, CD11c, CD16+/- | ||
P_4 | 30 | AML | M2 | (gate ≈45%) CD34+, CD13+, HLA-, DR+, CD19+, CD45RA+, CD71+, CD117+, MPO+ | |
P_5 | 58 | AML | M2 | CD33+, CD13-, CD11c+, CD11b+/-, CD117+/-, CD34+/-, DR+, MPO- | |
P_6 | 63 | AML | M1 | CD13+/-, CD33+, CD117+/-, CD14+/-, CD34+/-, CD45+/- |